Skip to main content

Table 2 Expression of glutamine metabolism-related proteins according to the histologic subtype of PTC

From: Expression of serine/glycine metabolism-related proteins is different according to the thyroid cancer subtype

Parameters

Total n = 344 (%)

Histologic subtype

p value

BRAF V600E mutation status

p value

Conventional type n = 304 (%)

Follicular variant n = 40 (%)

No mutation n = 106 (%)

Mutation n = 238 (%)

PHGDH in tumor

0.564

 

<0.001

 Negative

126 (36.6)

113 (37.2)

13 (32.5)

 

63 (59.4)

63 (26.5)

 

 Positive

218 (63.4)

191 (62.8)

27 (67.5)

 

43 (40.6)

175 (73.5)

 

PSAT1 in tumor

0.501

 

0.001

 Negative

280 (81.4)

249 (81.9)

31 (77.5)

 

97 (91.5)

183 (76.9)

 

 Positive

64 (18.6)

55 (18.1)

9 (22.5)

 

9 (8.5)

55 (23.1)

 

PSPH in tumor

0.041

 

<0.001

 Negative

300 (87.2)

261 (85.9)

39 (97.5)

 

104 (98.1)

196 (82.4)

 

 Positive

44 (12.8)

43 (14.1)

1 (2.5)

 

2 (1.9)

42 (17.6)

 

SHMT1 in tumor

0.018

 

0.001

 Negative

236 (68.6)

202 (66.4)

34 (85.0)

 

86 (81.1)

150 (63.0)

 

 Positive

108 (31.4)

102 (33.6)

6 (15.0)

 

20 (18.9)

88 (37.0)

 

SHMT1 in stroma

<0.001

 

<0.001

 Negative

212 (61.6)

176 (57.9)

36 (90.0)

 

83 (78.3)

129 (54.2)

 

 Positive

132 (38.4)

128 (42.1)

4 (10.0)

 

23 (21.7)

109 (45.8)

 

GLDC in tumor

0.116

 

<0.001

 Negative

285 (82.8)

248 (81.6)

37 (92.5)

 

99 (93.4)

186 (78.2)

 

 Positive

59 (17.2)

56 (18.4)

3 (7.5)

 

7 (6.6)

52 (21.8)

 
  1. PTC papillary thyroid carcinoma; PHGDH phosphoglycerate dehydrogenase; PSAT phosphoserine aminotransferase; PSPH phosphoserine phosphatase; SHMT serine hydromethyl transferase; GLDC glycine decarboxylase
  2. Italic values represent p < 0.05